|

An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2023-09-21
Est. completion2028-05-21
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT05914766

Summary

The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Age≥18 years
2. Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
3. Able to complete study procedures English or with the assistance of an interpreter

Exclusion Criteria:

1. Comorbid health condition that would interfere with study participation, as identified by cancer care team
2. Has undergone treatment for a prior colorectal cancer

Conditions3

CancerRectal CancerSelf Efficacy

Locations2 sites

Massachusetts General Hospital
Boston, Massachusetts, 02114
Kelsey Lau-Min, MD, MSCE617-724-4000klau-min@mgh.harvard.edu
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
Christo Manz, MD, MSHP617-632-3315christopher_manz@dfci.harvard.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.